7 Key Insights on Post-Market Surveillance under ANVISA Navigating Regulatory Landscapes in Latin America Overview This article underscores the critical importance of post-market surveillance as manda...
7 Key Insights on Post-Market Surveillance under ANVISA Navigating Regulatory Landscapes in Latin America Overview This article underscores the critical importance of post-market surveillance as mandated by ANVISA, highlighting its pivotal role in safeguarding the safety and efficacy of medical devices in Brazil. It is essential for companies to establish robust reporting systems and conduct regular risk assessments. Furthermore, maintaining effective communication with regulatory authorities is vital for compliance with evolving regulations, ultimately enhancing patient safety. Introduction In Brazil's rapidly evolving healthcare landscape, the significance of robust post-market surveillance for medical devices is paramount. As regulatory bodies like ANVISA tighten their grip on compliance, companies are compelled to navigate a complex web of requirements to ensure patient safety and device efficacy. With over two decades of experience, bioaccess® emerges as a pivotal partner, offeri…